ABO-Incompatible Platelet Transfusions and Mortality Risk in Patients With Intracranial Hemorrhage
Acute platelet transfusion practice remains prevalent in ICH, and platelet transfusion-related 30-day mortality risk may be influenced by ABO-incompatible platelet units. Clinical trials are needed to assess whether transfusion practice changes in providing ABO-matched platelets can improve outcomes in certain patients with ICH.
Authors
- Matthew S. Karafin (ORCID: https://orcid.org/0000-0001-7533-6842)
- Melissa M. Cushing (ORCID: https://orcid.org/0000-0001-8042-1494)
- Jonathan M. Davis (ORCID: https://orcid.org/0000-0001-5209-9768)
- Deborah B. Bookwalter
- Travis Lee
- Jerome L. Gottschall (ORCID: https://orcid.org/0000-0003-2241-2471)
- Grant Sinson
- Elizabeth F. Stone (ORCID: https://orcid.org/0000-0002-4148-7957)
- Ritchard G. Cable
- Eldad A. Hod (ORCID: https://orcid.org/0000-0002-2367-9509)
- David Roh (ORCID: https://orcid.org/0000-0003-1927-7686)
- Claude Hemphill
- S. H. Kleinman
- Bryan Spencer
- Emily J. Gilmore
- Patrick Mitchell
- Alan E. Mast
Institutions
- University of North Carolina at Chapel Hill (US)
- Froedtert Hospital (US)
- Yale New Haven Hospital (US)
- Westat (United States) (US)
- American Red Cross (US)
- University of British Columbia (CA)
- University of California, San Francisco (US)
- Cornell University (US)
- Versiti Blood Center of Wisconsin (US)
- Columbia University (US)
Publication Details
- Journal
- Neurosurgery
- Published
- 2026-03-27
- DOI
- https://doi.org/10.1227/neu.0000000000004006
- Primary Topic
- Blood transfusion and management
- Type
- article
- Field-Weighted Citation Impact
- 0.00